Leucocyte migration inhibition in Behçet's disease.
The leucocyte migration inhibition (LIF) was investigated in 16 patients with Behçet's disease, 5 while in the active stage of the process, 3 both during relapse and remission, and 8 during remission of symptoms. In all patients skin tests with various antigens and with a needle prick and physiological saline were simultaneously performed. The results indicate a strong correlation between the activity of the disease, skin reactivity and the reactivity of LIF.
D000293:Adolescent; D000328:Adult; D001528:Behcet Syndrome / Q000276:immunology*; D002464:Cell Migration Inhibition; D005260:Female; D006801:Humans; D007111:Immunity, Cellular; D007962:Leukocytes / Q000276:immunology*; D008222:Lymphokines; D008264:Macrophages / Q000276:immunology; D008297:Male; D008875:Middle Aged; D012882:Skin Tests
D008222:Lymphokines